Replies to post #616367 on ORIONS Money Stocks

[oldstocks]

Yanke…. You feel TCON is going to turn around and head north next week?

Tracon said it has licensed its proprietary PDP of CRO-independent clinical research to a clinical-stage biotech firm for a $3M upfront payment.

Tracon hinted more licensed deals may be in the future as they are looking for more biotech firms who may be interested

I think that is a big deal.
$3 million is half of TCON market value.